Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report) shot up 0.7% on Monday . The stock traded as high as $1.56 and last traded at $1.50. 68,849 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.49.
BioRestorative Therapies Stock Performance
The stock has a 50-day simple moving average of $1.50 and a 200 day simple moving average of $1.62. The stock has a market capitalization of $2.61 billion, a P/E ratio of -1.49 and a beta of 102.36.
About BioRestorative Therapies
(
Get Free Report)
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
Before you consider BioRestorative Therapies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.
While BioRestorative Therapies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
